Longevity & quality of life

Risk reduction and healthspan, driven by your labs and your family history rather than by a protocol someone wrote for everybody.

Metformin

Off-labelOral

Insulin-sensitising agent, widely studied in longevity contexts.

Evidence

Decades of safety data in diabetes. The longevity case rests on observational data and secondary findings, not a completed trial — the trial designed to answer it directly has never been funded. Requires kidney and liver function first.

GLP-1 receptor agonists

FDA-approvedInjection

Semaglutide, tirzepatide. Branded products only.

Evidence

Large randomised trials for weight and cardiovascular outcomes. Among the best-evidenced drugs of the last decade. Subject to eligibility criteria and supply.

Statins

FDA-approvedOral

Lipid lowering, guided by your numbers and your family history.

Evidence

Among the strongest evidence bases in all of medicine for cardiovascular risk reduction. The side-effect reputation online runs well ahead of what trials show.

Comprehensive lab panels

FDA-approvedLab

Metabolic, lipid, thyroid, inflammatory markers.

Evidence

Ordered before most interventions here. Several agents in this catalogue cannot be safely prescribed without them.

How to read the tags

FDA-approved: Approved by the FDA for this use.
Off-label: An approved drug used outside its labeled indication — ordinary, legal medicine at a physician's discretion.
Compounded: Prepared by a compounding pharmacy. Not FDA-approved as a finished product.
Cosmetic / OTC: Sold as a cosmetic or over-the-counter ingredient, not a prescription drug.
Research only: Investigational. No established basis for human prescribing. Listed for transparency; not offered.

Other pillars

Informational only. Not a promise to prescribe, and not medical advice. Whether any agent is appropriate for you is decided by a licensed physician after reviewing your intake, your history, and — where required — your labs.